BIOGEN INC. Treasury Stock, Shares
BIOGEN INC. (BIIB) had Treasury Stock, Shares of 23.80 million shares as of 2022-12-31, per its 10-K filed 2023-02-15.
Discontinued › Notes › Shares
us-gaap:TreasuryStockShares · last filed 2023-02-15
- 2022-12-31: Treasury Stock, Shares 23.80M shares.
- 2021-12-31: Treasury Stock, Shares 23.80M shares.
- 2020-12-31: Treasury Stock, Shares 23.80M shares.
- 2019-12-31: Treasury Stock, Shares 23.80M shares.
| Period end | Treasury Stock, Shares | Treasury Stock, Shares as first filed |
|---|---|---|
| 2022-12-31 | 23.80M shares 10-K · filed 2023-02-15 | |
| 2021-12-31 | 23.80M shares 10-K · filed 2023-02-15 | |
| 2020-12-31 | 23.80M shares 10-K · filed 2022-02-03 | |
| 2019-12-31 | 23.80M shares 10-K · filed 2021-02-03 | |
| 2018-12-31 | 23.80M shares 10-K · filed 2020-02-06 | |
| 2017-12-31 | 23.80M shares 10-K · filed 2019-02-06 | |
| 2016-12-31 | 22.60M shares 10-K · filed 2018-02-01 | |
| 2015-12-31 | 22.60M shares 10-K · filed 2017-02-02 | |
| 2014-12-31 | 22.60M shares 10-K · filed 2016-02-03 | 0.00 shares 10-K · filed 2015-02-04 |
| 2013-12-31 | 19.64B shares 10-K · filed 2015-02-04 | |
| 2012-12-31 | 17.66B shares 10-K · filed 2014-02-06 | |
| 2011-12-31 | 13.52B shares 10-K · filed 2013-02-05 | 13.52M shares 10-K · filed 2012-02-03 |
| 2010-12-31 | 7.66M shares 10-K · filed 2012-02-03 | |
| 2009-12-31 | 13.64M shares 10-K · filed 2011-02-04 | |
| 2008-12-31 | 9.21M shares 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |